Are We Aiming at the Right End Points in Crohn’s Disease?

Originally published by our sister publication Gastroenterology & Endoscopy NewsBy Gina ShawLAS VEGAS—Treat-to-target strategies have become foundational to Crohn’s disease management, but at the 2026 Crohn’s & Colitis Congress, experts focused on a central question: Are the end points being chased in trials and guidelines the ones that actually predict meaningful outcomes in real-world patients?The STRIDE II recommendations from the International Organization for the S